New eye scanner could replace dye injections for retinal disease

NCT ID NCT03279939

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new imaging device called OCT angiography (OCTA) that takes 3D pictures of blood vessels in the back of the eye without needing dye injections. Researchers compared OCTA images to standard dye-based imaging in 88 people with retinal blood vessel problems or normal eyes. The goal was to see if OCTA provides good image quality and shows clinically useful details.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this imaging method could replace dye-based tests, making eye exams faster and safer for patients with retinal conditions.

What could go wrong

This is a small, completed study focused on image quality, not treatment. The device may not be better than existing methods for all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

branch retinal artery occlusion central retinal vein occlusion diabetic retinopathy retinal vascular disorder wet macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Retina Consultants of Houston

    Houston, Texas, 77030, United States